Article

Osteoporosis, More Costly Than You Think

An Argentinean Epidemiological Study on the Prevalence of Osteoporosis and the costs associated with the disease was highlighted at a press conference held by the International Osteoporosis Foundation Latin America regional office in Buenos Aires, Argentina.

An Argentinean Epidemiological Study on the Prevalence of Osteoporosis and the costs associated with the disease was highlighted at a press conference held by the International Osteoporosis Foundation Latin America regional office in Buenos Aires, Argentina.

Among the key findings were:

• In Argentina, bone mineral density studies reveal that one out of three women aged 50 or over suffers from osteoporosis.

• The prevalence of vertebral fractures in Argentinean women aged 50 or older is 16%.

• Over 34.000 hip fractures occur every year among the 50 years or older population, with an average of 90 fractures per day.

• The cost of vertebral and hip osteoporotic fractures is estimated in approximately 250 million dollars per year in Argentina.

• Risk factors for hip fracture include cognitive impairment, previous falls, low calcium intake during youth, vitamin D deficiency, advanced age, and current low calcium intake.

For more, check out this press release.

Related Videos
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
© 2024 MJH Life Sciences

All rights reserved.